Jannick Imbach, a scientist at IOB, chose automation to increase the efficiency and throughput of his lab’s molecular cloning protocols Gene therapy is a technique whereby synthetic DNA constructs are introduced into host cells to treat diseases. The research involved in discovering gene therapies requires a substantial amount of time-consuming… Read More

Single-cell RNA sequencing, or scRNAseq, enables transcriptomic analysis at a single-cell resolution, which can inform us of rare but important cell populations. Although the use of scRNA-seq technology has become increasingly popular, the cost remains quite expensive. Beyond the cost of the sequencing platform and each individual run, the library… Read More

Stephane Plaisance, a molecular biologist at VIB, championed introducing automation to improve his lab’s NGS library prep workflows for long- and short-read sequencing. A rising demand for sequencing services is pushing laboratories to find ways to increase capacity and improve workflow efficiency. Laboratory automation is an effective means to both… Read More

AIM Biotech is using the OT-2 to implement automated drug discovery on in vitro platforms that provide more predictive data and higher throughput. When scientists at AIM Biotech developed their idenTx organ-on-a-chip (OOAC) platform for human cell-based drug discovery, they were focused on creating a system that could… Read More

Michael Rourke, a doctoral chemistry researcher at Northwestern University, is advancing organic chemistry research using the OT-2 and the Opentrons Protocol Designer. Inspired by the potential to increase accuracy and precision while freeing his team from mundane repetitive tasks, Michael Rourke led his Northwestern University organic chemistry lab to transition… Read More

Alaric Taylor, Yann Mamie, and Stefan Guldin of the Adaptive & Responsive Nanomaterials Group at UCL are fast-tracking materials innovation using the OT-2 and the Opentrons Python Protocol API. Stefan Guldin, Associate Professor, leads the Adaptive & Responsive Nanomaterials Group (AdReNa Group), where … Read More

Parhelia Bio is disrupting the automated staining market. They’ve created a flexible, affordable slide and coverslip staining device using Opentrons. Here’s how. Nikolay Samusik and Yury Goltsev, co-founders of Biotech startup Parhelia Bio, created (and patented) a plug-in module that turns… Read More

Using Opentrons COVID-19 testing systems, #COVIDWarriors were able to process 10,000 tests per day across Spain to scale up population-level testing. The coronavirus pandemic pushed global health systems to their limits. In early March, the World Health Organization’s Director-General Tedros Adhanom Ghebreyesus recommended that all nations “test,… Read More

Anatoliy Trokhymchuk and Mengying Liu conduct mass spectrometry applications including MALDI-TOF MS target preparation with the Opentrons OT-2. Here’s how. Anatoliy Trokhymchuk is the Chief Scientific Officer for Prairie Diagnostic Services Inc. (PDS), a regional animal health lab associated with University… Read More

Fidabio creates devices to analyze protein interactions for biologic drug development using the OT-2 and the Opentrons Python Protocol API. Here’s how. Brian Sørensen is the CEO of Fidabio. Henrik Jensen is the CSO. Fidabio creates devices to analyze protein interactions for biologic drug development. They use… Read More